Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This ...

The phase 3 COAST trial investigating 2 mg sozinibercept for the treatment of wet age-related macular degeneration in ...

Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial’s primary ...

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

Opthea was making preparations for the potential launch of a new eye disease drug onto the market. | A month ago, Opthea was ...

Macular degeneration and cataracts are two different eye conditions that have some shared symptoms, including blurriness and vision loss. The risk for both increases with age. Macular degeneration ...

Central serous retinopathy and macular degeneration both affect the retinas in your eyes, but one does not lead to the other. They share similar symptoms but have differing causes and risk factors.

Incorporate omega-3s into your diet: Foods like fish have been shown to reduce the risk of macular degeneration. Don’t forget to add a handful of walnuts to your meals as they’re also packed with ...

Biotechnology firm Opthea has warned investors its solvency is in question after the failure of a major clinical trial into ...

Surrozen (SRZN) announced that the company will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, ...